122 related articles for article (PubMed ID: 9041683)
1. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization.
Gilham DE; Cairns W; Paine MJ; Modi S; Poulsom R; Roberts GC; Wolf CR
Xenobiotica; 1997 Jan; 27(1):111-25. PubMed ID: 9041683
[TBL] [Abstract][Full Text] [Related]
2. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT
J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.
Bajpai P; Sangar MC; Singh S; Tang W; Bansal S; Chowdhury G; Cheng Q; Fang JK; Martin MV; Guengerich FP; Avadhani NG
J Biol Chem; 2013 Feb; 288(6):4436-51. PubMed ID: 23258538
[TBL] [Abstract][Full Text] [Related]
5. Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus).
Uehara S; Uno Y; Inoue T; Murayama N; Shimizu M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 May; 43(5):735-42. PubMed ID: 25735838
[TBL] [Abstract][Full Text] [Related]
6. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase.
Modi S; Gilham DE; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
Biochemistry; 1997 Apr; 36(15):4461-70. PubMed ID: 9109653
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models.
Chattopadhyay M; Chowdhury AR; Feng T; Assenmacher CA; Radaelli E; Guengerich FP; Avadhani NG
J Biol Chem; 2019 Jun; 294(26):10336-10348. PubMed ID: 31113867
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells.
Mann A; Tyndale RF
Eur J Neurosci; 2010 Apr; 31(7):1185-93. PubMed ID: 20345925
[TBL] [Abstract][Full Text] [Related]
9. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
10. Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Shen HW; Wu C; Jiang XL; Yu AM
Biochem Pharmacol; 2010 Jul; 80(1):122-8. PubMed ID: 20206139
[TBL] [Abstract][Full Text] [Related]
11. Characterization and localization of cytochrome P450 mediated metabolism of MPTP to nor-MPTP in mouse brain: relevance to Parkinson's disease.
Upadhya SC; Boyd MR; Ravindranath V
Neurotox Res; 2001 Aug; 3(4):369-80. PubMed ID: 14715467
[TBL] [Abstract][Full Text] [Related]
12. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation.
Fonne-Pfister R; Bargetzi MJ; Meyer UA
Biochem Biophys Res Commun; 1987 Nov; 148(3):1144-50. PubMed ID: 3500719
[TBL] [Abstract][Full Text] [Related]
13. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes.
Narimatsu S; Tachibana M; Masubuchi Y; Suzuki T
Chem Res Toxicol; 1996; 9(1):93-8. PubMed ID: 8924622
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain.
Chinta SJ; Pai HV; Upadhya SC; Boyd MR; Ravindranath V
Brain Res Mol Brain Res; 2002 Jun; 103(1-2):49-61. PubMed ID: 12106691
[TBL] [Abstract][Full Text] [Related]
16. MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes.
Fernandez-Gonzalez A; Pérez-Otaño I; Morgan JI
Eur J Neurosci; 2000 May; 12(5):1573-83. PubMed ID: 10792435
[TBL] [Abstract][Full Text] [Related]
17. Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Hare DJ; Adlard PA; Doble PA; Finkelstein DI
Metallomics; 2013 Feb; 5(2):91-109. PubMed ID: 23322189
[TBL] [Abstract][Full Text] [Related]
18. Presence of splice variant forms of cytochrome P4502D1 in rat brain but not in liver.
Chinta SJ; Pai HV; Ravindranath V
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):81-92. PubMed ID: 15857671
[TBL] [Abstract][Full Text] [Related]
19. Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
Cashman JR; Ziegler DM
Mol Pharmacol; 1986 Feb; 29(2):163-7. PubMed ID: 3485239
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
Mann A; Miksys SL; Gaedigk A; Kish SJ; Mash DC; Tyndale RF
Neurobiol Aging; 2012 Sep; 33(9):2160-71. PubMed ID: 21958961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
